 - Patients must have stage II-III carcinoma of head and neck, including oral cavity, pharynx, larynx, paranasal sinuses and cervical esophagus. Selected patients with stage disease T will also be considered for enrolment. Therapy is given with curative intent. Patients with clinical N2 or N3 disease are excluded. 